Glucagon for Injection (Fresenius Kabi USA)

DRUG3 trials

Sponsors

Fresenius Kabi USA, LLC, Joslin Diabetes Center

Conditions

Bariatric SurgeryHypoglycemiaHypoglycemia, Reactive

Phase 1

Bioequivalence of Fresenius Kabi USA, LLC Glucagon for SC Injection Compared to Glucagon for Injection (Bedford Laboratories)

CompletedNCT02086227

Fresenius Kabi USA, LLCHypoglycemia

Start: 2013-05-31End: 2013-06-30Updated: 2014-03-13

Phase 4

Glucagon Dose-Response in Patients With Post-Bariatric Hypoglycemia

Active, not recruitingNCT06986603

Joslin Diabetes CenterBariatric Surgery, Hypoglycemia, Hypoglycemia, Reactive

Start: 2024-11-26End: 2026-09-01Target: 28Updated: 2026-02-06

Post-Prandial Carbohydrate Metabolism in Individuals With and Without Post-Bariatric Surgery Hypoglycemia (PBH)

RecruitingNCT07818707

Joslin Diabetes CenterBariatric Surgery, Hypoglycemia, Hypoglycemia, Reactive

Start: 2026-01-27End: 2027-01-01Target: 40Updated: 2026-09-14